Search results
Recognizing signs of breast cancer in older women
Medical News Today· 6 days agoMost breast cancers are found in females aged 45 years or older, with the average age of diagnosis being around 62 years. Early signs of breast ...
DeSantis announces new legislation and funding for children’s cancer and rare diseases
Sun-Sentinel· 24 minutes agoThe funding is part of the 2024-2025 state budget and represents a record investment in cancer...
Medicare must fund blood-based cancer screenings. NY's delegatin must act
Lohud | The Journal News via Yahoo News· 28 minutes agoCancer Early Detection Screening Coverage Act, that would cut through this red tape and create a...
What is preventative chemotherapy? Kate Middleton’s cancer treatment explained
The Independent via Yahoo News· 4 days agoFor example, it is currently used for people who have not developed breast cancer but are at...
Cancer risks are far higher for LGBTQ folks. Here's how health justice groups are fighting back
Salon via Yahoo News· 8 hours ago"Starting before diagnosis, disparities for SMW (sexual minority women) have been identified in ...
AstraZeneca's Advanced Breast Cancer Drug Fails to Meet Primary Goals
Morningstar· 15 hours agoAstraZeneca said a late-stage study showed that its therapy for advanced or metastatic triple-negative breast cancer didn't meet its primary goals. The ...
Combination therapy shows promise in subset of breast cancers
Medical Xpress· 1 day agoCombining two cancer drugs may be a promising treatment for advanced metastatic breast cancer,...
Surviving to Thriving: Enhancing QoL in Breast Cancer
Medscape· 5 days agoThe growing number of breast cancer survivors highlights the need for holistic and coordinated...
AstraZeneca's Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial -...
Benzinga· 8 hours agoThe study did not meet the dual primary endpoints of improvement in overall survival (OS) versus...
A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?
Medscape· 6 days agoAdding abemaciclib to an aromatase inhibitor improved overall survival in HR+/HER2− advanced breast ...